Press Release

RepliCel Life Sciences Announces the Closing of the First Tranche Private Placement and Amendments to Debt Settlement

4 years ago Jul 16, 2020

VANCOUVER, BC – July 15, 2020 - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:...

Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays

5 years ago Apr 23, 2020

VANCOUVER, BC – 22 April, 2020 – Replicel Life Sciences Inc. ("Company" or "Replicel") has...

Publication of Clinical Data Confirms RepliCel’s Treatment for Androgenic Alopecia Effective in Men and Women

5 years ago Mar 23, 2020

A randomized, placebo-controlled, double-blinded clinical study in Japan testing a one-time injection of RCH-01 in...

Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies

5 years ago Mar 11, 2020

Timely patent-grants support next steps in RepliCel’s First-in-Japan strategyVANCOUVER, BC, CANADA – 10 March 2020 – RepliCel Life...

Japan's Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products

5 years ago Mar 11, 2020

RepliCel completes the second of three formal consultation reviews with Japan's Pharmaceuticals and Medical Devices Agency in...

Production of Dermal Injectors Delayed by China Work Stoppage Affecting Critical Component

5 years ago Mar 11, 2020

Production of Dermal Injectors Delayed by China Work Stoppage Affecting Critical ComponentInitial run of commercial-grade...

Commercial-Grade Replicel Injectors RepliCel in Production

5 years ago Feb 03, 2020

Commercial-Grade Replicel Injectors RepliCel in ProductionInitial units will be dedicated to the functional and clinical testing needed...

RepliCel Announces its Incoming Board of Directors

5 years ago Dec 23, 2019

RepliCel Announces its Incoming Board of DirectorsSuccessful Annual General Meeting Confirms Director Slate for 2020VANCOUVER,...

RepliCel Provides 2019 Year-End Update

5 years ago Nov 26, 2019

RepliCel Provides 2019 Year-End UpdateNotable Milestones for the Company’s ProgramsVANCOUVER, BC, CANADA – 26 November 2019 – RepliCel...

Clinical Data Published from RepliCel’s Skin Rejuvenation Study

5 years ago Sep 24, 2019

Clinical Data Published from RepliCel’s Skin Rejuvenation StudyA paper entitled, “Autologous Cell Therapy for Aged Human...

RepliCel Closes First Tranche of Private Placement Financing of Preferred Shares

5 years ago Sep 12, 2019

RepliCel Closes First Tranche of Private Placement Financing of Preferred SharesNot for distribution to U.S....

RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China

5 years ago Sep 10, 2019

RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in ChinaYOFOTO (China)...

RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector

5 years ago Aug 29, 2019

RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy...

RepliCel Secures Several New Patents for its Regenerative Medicine Technologies

6 years ago Apr 16, 2019

RepliCel Secures Several New Patents for its Regenerative Medicine TechnologiesTendon Regeneration, Skin Rejuvenation and Dermal Injector...

RepliCel's Licensee Building Momentum in China with Facility and Team

6 years ago Mar 26, 2019

RepliCel's Licensee Building Momentum in China with Facility and TeamYOFOTO (China) Health Announces Initiation of...

RepliCel Reignites its First-in-Japan Strategy

6 years ago Mar 19, 2019

RepliCel Reignites its First-in-Japan StrategyNext-stage trials in Japan present market launch opportunities for RepliCel’s skin...

RepliCel CEO Provides 2019 Shareholder Update

6 years ago Mar 05, 2019

With a new strategic plan, RepliCel prioritizes focus on commercial revenueVANCOUVER, BC, CANADA – 5 March, 2019 –...

RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs

6 years ago Nov 05, 2018

Appointment of Dr. Goessens-Rueck strengthens management team and fulfils commitment to promote female leadership in...

RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada

6 years ago Oct 17, 2018

The National Sciences and Engineering Research Council of Canada has funded a University of Victoria...

RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada (Copy)

6 years ago Oct 17, 2018

The National Sciences and Engineering Research Council of Canada has funded a University of Victoria...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.